Zinterol
From Wikipedia, the free encyclopedia
Names | |
---|---|
IUPAC name
N-[5-[2-[(1,1-dimethyl-2-phenylethyl)amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulfonamide
|
|
Identifiers | |
37000-20-7 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL1243407 |
ChemSpider | 34825 |
ECHA InfoCard | 100.189.867 |
3466 | |
MeSH | Zinterol |
PubChem | 37990 |
UNII | 7167N7AJJR |
|
|
|
|
Properties | |
C19H26N2O4S | |
Molar mass | 378.49 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
Zinterol is a beta-adrenergic agonist.[1]
Its structure is based on soterenol (antiarrhythmic) and phentermine.
References[edit]
- ^ Heubach JF, Graf EM, Molenaar P, et al. (May 2001). "Murine ventricular L-type Ca2+ current is enhanced by zinterol via β1-adrenoceptors, and is reduced in TG4 mice overexpressing the human β2-adrenoceptor". Br. J. Pharmacol. 133 (1): 73–82. doi:10.1038/sj.bjp.0704045. PMC 1572761. PMID 11325796.
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |